3-167467232-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006217.6(SERPINI2):c.301C>A(p.Gln101Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,612,580 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006217.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SERPINI2 | NM_006217.6 | c.301C>A | p.Gln101Lys | missense_variant | 3/9 | ENST00000264677.9 | |
SERPINI2 | NM_001012303.3 | c.301C>A | p.Gln101Lys | missense_variant | 4/10 | ||
SERPINI2 | NM_001394327.1 | c.301C>A | p.Gln101Lys | missense_variant | 4/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SERPINI2 | ENST00000264677.9 | c.301C>A | p.Gln101Lys | missense_variant | 3/9 | 1 | NM_006217.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151980Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250128Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135240
GnomAD4 exome AF: 0.000110 AC: 160AN: 1460600Hom.: 0 Cov.: 32 AF XY: 0.000109 AC XY: 79AN XY: 726574
GnomAD4 genome AF: 0.0000526 AC: 8AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.301C>A (p.Q101K) alteration is located in exon 3 (coding exon 2) of the SERPINI2 gene. This alteration results from a C to A substitution at nucleotide position 301, causing the glutamine (Q) at amino acid position 101 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at